Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANAGRELIDE vs ANIDULAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANAGRELIDE vs ANIDULAFUNGIN: Safety Overview

Metric ANAGRELIDE ANIDULAFUNGIN
Total FAERS Reports 1,336 701
Deaths Reported 131 325
Death Rate 9.8% 46.4%
Hospitalizations 580 287
Average Patient Age 69.6 yrs 53.3 yrs
% Female Patients 58.5% 40.0%
FDA Approval Date Apr 18, 2005 Feb 17, 2006
Manufacturer ANI Pharmaceuticals, Inc. Roerig
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription